Company Snapshot

Investment Thesis

Altria protects outsized cash flow from Marlboro while investing in smoke-free platforms and disciplined capital returns. U.S.-centric pricing power and reduced-risk products help offset secular cigarette volume declines.

  • Pricing Durability: Marlboro’s premium positioning and retail execution support above-industry price/mix.
  • Smoke-Free Transition: On! oral nicotine, NJOY ACE devices, and strategic cannabis stakes extend portfolio optionality.
  • Shareholder Yield: High single-digit dividend yield and buybacks distribute surplus cash to investors.

Strategic Mix

Combustible Cigarettes Marlboro and value brands dominating the U.S. market
Oral Tobacco & Nicotine Pouches Copenhagen, Skoal, and On! growth assets
E-Vapor NJOY ACE closed system and distribution through retail channels
Equity Stakes & Ventures Anheuser-Busch InBev, Cronos, and emerging wellness bets

Mix approximates Altria’s FY2024 revenue contribution by category.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Regulatory Strategy

Engagement with FDA on product standards and menthol rules preserves ability to innovate.

Cost Rationalization

Manufacturing modernization and portfolio simplification defend margins as volumes decline.

Diversified Wallet

Selective investments in cannabis and reduced-risk platforms offer upside beyond combustibles.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...